PTEN and acute myeloid leukemia: Moreover, circRNAs can offer value as diagnostic biomarkers in this oncogenic context, as in the case of circ_0002232, which offers value as a biomarker of AML that has been posited to function through a circ_0002232/miR‐92a‐3p/PTEN ceRNA regulatory pathway.25